A Novel Homozygous Pathogenic Variant in CYP11B1 in a Female Iranian Patient with 11B Hydroxylase Deficiency
Laboratory Medicine · 2023
DOI: 10.1093/labmed/lmac141 ↗Kurz gefasst
Fallbericht in der Zeitschrift Laboratory Medicine, 2023. Verfasst von Marziyeh Hoseinzadeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Isfahan University of Medical Science.
Abstract (Originalsprache)
Objective
Congenital adrenal hyperplasia (CAH) addresses a number of autosomal recessive disorders characterized by the enzyme defects in steroid hormones biosynthesis. The second common form of CAH is caused by mutations in the CYP11B1 gene. Here, we reveal a novel mutation in the CYP11B1 gene related to the 11βOHD phenotype. Methods and Results Sequence analysis of the CYP11B1 gene in a 19-year-old Iranian woman with the 11βOHD phenotype was performed. In silico analysis and molecular docking were done. A novel missense homozygous variant c.1351C > T (p.L451F) in the CYP11B1 gene was identified in the patient and, according to American College of Medical Genetics and Genomics criteria, was categorized as likely pathogenic. Protein docking showed destructive effects of the variant on the CYP11B1 protein-ligand interactions.
Conclusion
This study broadens the CYP11B1 mutation spectrum and introduces the novel p.L451F likely pathogenic variant leading to destructive effects on protein-ligand interactions. Our results provide reliable information for genetic counseling and molecular diagnostics of CAH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Molecular Medicine, School of Advanced Technologies, Sahrekord University of Medical Sciences, Shahrekord, Iran.
- Metabolic Liver Disease Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Noncommunicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
Förderung
- Isfahan University of Medical Science
Zitieren
APA
Hoseinzadeh, M., Molavi, N., Norouzi, M., Aghaei, S., Zeinalian, M., Hashemipour, M., & Tabatabaiefar, M. A. (2023). A Novel Homozygous Pathogenic Variant in CYP11B1 in a Female Iranian Patient with 11B Hydroxylase Deficiency. Laboratory Medicine. https://doi.org/10.1093/labmed/lmac141
Vancouver
Hoseinzadeh M, Molavi N, Norouzi M, Aghaei S, Zeinalian M, Hashemipour M, et al. A Novel Homozygous Pathogenic Variant in CYP11B1 in a Female Iranian Patient with 11B Hydroxylase Deficiency. Laboratory Medicine. 2023. doi:10.1093/labmed/lmac141
BibTeX
@article{Hoseinzadeh2023,
author = {Hoseinzadeh, Marziyeh and Molavi, Newsha and Norouzi, Mahnaz and Aghaei, Shahrzad and Zeinalian, Mehrdad and Hashemipour, Mahin and Tabatabaiefar, Mohammad Amin},
title = {A Novel Homozygous Pathogenic Variant in CYP11B1 in a Female Iranian Patient with 11B Hydroxylase Deficiency},
journal = {Laboratory Medicine},
year = {2023},
doi = {10.1093/labmed/lmac141}
}
EUVIMED